Form 4: Myriam Curet, Director at Inspire Medical Systems, Acquires Restricted Stock Units

Director Myriam Curet acquired 1,266 Restricted Stock Units (RSUs) in Inspire Medical Systems, Inc.

Summary

• On May 1, 2025, Myriam Curet, a director at Inspire Medical Systems, Inc., acquired 1,266 Restricted Stock Units (RSUs).
• Each RSU represents a contingent right to receive one share of common stock.
• The RSUs will vest on the earlier of the first anniversary of the grant date or immediately prior to a Change of Control, subject to continued employment.
• Following the transaction, Curet directly owns 3,366 shares of common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of an RSU grant, which is a common practice.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future.

Future Outlook

The vesting of the RSUs is contingent upon continued employment and could be accelerated by a Change of Control event.

Industry Context

Form 4 filings are routine disclosures for corporate insiders and provide transparency into their transactions in company stock. This is a standard practice in publicly traded companies.

Comparison to Industry Standards

• Equity compensation in the form of RSUs is a common practice among publicly traded companies to align the interests of directors and employees with those of shareholders.
• Companies like Medtronic and ResMed also use similar equity-based compensation plans for their executives and directors.

Stakeholder Impact

• The RSU grant aligns the director's interests with those of the shareholders.

Key Dates

Keywords

RSU, Director, Form 4, INSP, Inspire Medical Systems, Beneficial Ownership, Myriam Curet